New HIV vaccine combo enters first human tests
NCT ID NCT06919016
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 39 times
Summary
This early-stage study tests two experimental HIV vaccines for the first time in people. The goal is to see if they are safe and how well the immune system responds. Forty-five healthy adults without HIV, aged 18 to 55, will receive the vaccines and be followed for about 16 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital (Site ID: 30007)
Boston, Massachusetts, 02215, United States
-
Columbia P&S CRS (Site ID: 30329)
New York, New York, 10032, United States
-
Seattle Vaccine and Prevention CRS (Site ID: 30331)
Seattle, Washington, 98104, United States
-
The Hope Clinic of the Emory Vaccine Center CRS (Site ID: 31440)
Decatur, Georgia, 30030, United States
-
University of Alabama Medical Center (Site ID: 31788)
Birmingham, Alabama, 35222, United States
-
University of Pittsburgh (Site ID: 1001)
Pittsburgh, Pennsylvania, 15213, United States
-
University of Rochester Medical Center (Site ID: 31467)
Rochester, New York, 14642, United States
-
Vanderbilt University Medical Center (Site ID: 30352)
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.